Correlation Between FactSet Research and Lipocine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FactSet Research and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FactSet Research and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FactSet Research Systems and Lipocine, you can compare the effects of market volatilities on FactSet Research and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FactSet Research with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of FactSet Research and Lipocine.

Diversification Opportunities for FactSet Research and Lipocine

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between FactSet and Lipocine is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding FactSet Research Systems and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and FactSet Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FactSet Research Systems are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of FactSet Research i.e., FactSet Research and Lipocine go up and down completely randomly.

Pair Corralation between FactSet Research and Lipocine

Considering the 90-day investment horizon FactSet Research Systems is expected to generate 0.18 times more return on investment than Lipocine. However, FactSet Research Systems is 5.62 times less risky than Lipocine. It trades about 0.21 of its potential returns per unit of risk. Lipocine is currently generating about -0.12 per unit of risk. If you would invest  46,083  in FactSet Research Systems on September 5, 2024 and sell it today you would earn a total of  2,469  from holding FactSet Research Systems or generate 5.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

FactSet Research Systems  vs.  Lipocine

 Performance 
       Timeline  
FactSet Research Systems 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in FactSet Research Systems are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, FactSet Research unveiled solid returns over the last few months and may actually be approaching a breakup point.
Lipocine 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.

FactSet Research and Lipocine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FactSet Research and Lipocine

The main advantage of trading using opposite FactSet Research and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FactSet Research position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.
The idea behind FactSet Research Systems and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.